BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 365788)

  • 21. Heat stability of Mycobacterium leprae immunogenicity.
    Shepard CC; Walker LL; van Landingham R
    Infect Immun; 1978 Oct; 22(1):87-93. PubMed ID: 365752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular immune responses of healthy and Mycobacterium leprae-inoculated armadillos (Dasypus novemcinctus).
    Rivero-Nava L; Quesada-Pascual F; Estrada-Garcia I; Estrada-Parra S; Santos-Argumedo L
    Int J Lepr Other Mycobact Dis; 1998 Dec; 66(4):485-7. PubMed ID: 10347570
    [No Abstract]   [Full Text] [Related]  

  • 23. Effective vaccination of mice against Mycobacterium leprae with density-gradient subfractions of soluble M. leprae proteins: clues to effective protein epitopes.
    Gelber RH; Hunter SW; Murray LP; Siu P; Tsang M; Brennan PJ
    Lepr Rev; 1994 Sep; 65(3):175-80. PubMed ID: 8942148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccine development. On relating immunology to the Third World: some studies on leprosy.
    Bloom BR; Salgame P; Mehra V; Kato H; Modlin R; Rea T; Brennan P; Convit J; Lugozi L; Snapper S
    Immunol Suppl; 1989; 2():87-9; discussion 91-2. PubMed ID: 2680926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunosuppression and cellular immunity reactions in leprosy patients treated with a mixture of Mycobacterium leprae and BCG.
    Rada EM; Convit J; Ulrich M; Gallinotto ME; Aranzazu N
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):646-50. PubMed ID: 2963084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress in the preparation of an antileprosy vaccine from armadillo-derived Mycobacterium leprae.
    Rees RJ
    Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):515-8. PubMed ID: 6368415
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunology and animal experimentation in leprosy.
    Shepard CC
    Cutis; 1976 Jul; 18(1):80-96. PubMed ID: 797549
    [No Abstract]   [Full Text] [Related]  

  • 28. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-leprosy vaccines--field trials and future prospects.
    Deo MG
    Indian J Lepr; 1984; 56(4):764-75. PubMed ID: 6442720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Protective properties of M. lufu in experimental leprosy].
    Iushin MIu; Kalianina OV
    Probl Tuberk; 1995; (2):47-8. PubMed ID: 7777465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitsuda-negative, resistant nine-banded armadillos and enhanced Mitsuda response to live M. leprae.
    Job CK; Truman RW
    Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):475-7. PubMed ID: 10700925
    [No Abstract]   [Full Text] [Related]  

  • 32. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ; Closs O; Belehu A
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Towards a vaccine against leprosy].
    Bloom BR
    Servir; 1985; 33(5):247-8, 253-5. PubMed ID: 3933117
    [No Abstract]   [Full Text] [Related]  

  • 34. Regarding analysis of vaccines.
    Convit J
    Int J Lepr Other Mycobact Dis; 1995 Dec; 63(4):576-7. PubMed ID: 8642226
    [No Abstract]   [Full Text] [Related]  

  • 35. Cell mediated and humoral immunity in "reversal reactions".
    Barnetson RS; Bjune G; Pearson JM; Kronvall G
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):267-74. PubMed ID: 776863
    [No Abstract]   [Full Text] [Related]  

  • 36. Induction of delayed-type hypersensitivity by ICRC anti-leprosy vaccine and the adoptive transfer of cell-mediated immunity in mice.
    Jeevan A; Bapat CV
    Indian J Lepr; 1984; 56(4):754-63. PubMed ID: 6398339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A critique on the interpretation of the lepromin reaction using heat-killed M. leprae vaccine.
    Mistry NF; Antia NH
    Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):110-3. PubMed ID: 2659695
    [No Abstract]   [Full Text] [Related]  

  • 38. Variable lepromin response to Mycobacterium leprae in resistant armadillos.
    Job CK; Kirchheimer WF; Sanchez RM
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):347-53. PubMed ID: 6685696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of hsp65 DNA vaccination carrying immunostimulatory DNA sequences (CpG motifs) against Mycobacterium leprae multiplication in mice.
    Nomaguchi H; Mukai T; Takeshita F; Matsuoka M; Maeda Y; Aye TM; Jahan N; Yogi Y; Endo M; Sato Y
    Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):182-90. PubMed ID: 12483966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comments on leprosy vaccination.
    Kato L
    Int J Lepr Other Mycobact Dis; 1989 Sep; 57(3):693-4. PubMed ID: 2674307
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.